2007
DOI: 10.4314/ejhd.v20i2.10019
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence and antimicrobial responses of <i>Shigella</i> isolates in HIV-1 infected and uninfected adult diarrhoea patients in north west Ethiopia

Abstract: Background: Shigella is one of the diarrhoea causing organisms found in HIV positive patients. But so far, the pattern of diarrhoeal agents caused by Shigella in AIDS patients has not been determined Objective: This study is thus aimed at determining the prevalence, antimicrobial susceptibility and resistance of Shigella isolates in HIV positive subjects. Methods: All stool samples taken from the subjects of this study were plated on the MacConkey agar and incubated at 35-37 0 C for 24 or 48 hrs. Biochemical a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
8
3

Year Published

2009
2009
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(24 citation statements)
references
References 10 publications
11
8
3
Order By: Relevance
“…The prevalence rate of Shigella species in this study was 7% which is closer to the studies conducted in Jimma by Beyene et al (9), in Gondar by Mitikie et al (8) , in North west Ethiopia by Andualem et al (24) and in Harar, by Reda et al (14), in which the prevalence rates were 5%, 5.2%, 8.7% and 6.7% respectively. But, it is lower than the rate reported in studies carried out at Tikur Anbessa, Ethio-Swedish Children's Hospital by Asrat et al (21), in Jimma by Mache (25), in Hawassa by Roma et al (10), in Indonesia by Herwana et al (26), and in Iran by Mashouf et al (27) where the prevalence rates were 11.7%, 20.1%, 34.5%, 9.3% and 9.8% respectively.…”
Section: Discussionsupporting
confidence: 84%
“…The prevalence rate of Shigella species in this study was 7% which is closer to the studies conducted in Jimma by Beyene et al (9), in Gondar by Mitikie et al (8) , in North west Ethiopia by Andualem et al (24) and in Harar, by Reda et al (14), in which the prevalence rates were 5%, 5.2%, 8.7% and 6.7% respectively. But, it is lower than the rate reported in studies carried out at Tikur Anbessa, Ethio-Swedish Children's Hospital by Asrat et al (21), in Jimma by Mache (25), in Hawassa by Roma et al (10), in Indonesia by Herwana et al (26), and in Iran by Mashouf et al (27) where the prevalence rates were 11.7%, 20.1%, 34.5%, 9.3% and 9.8% respectively.…”
Section: Discussionsupporting
confidence: 84%
“…In north-west Ethiopia, Shigella was recovered from 3.5% of HIV-1-seropositive patients, 5.1% of HIV-1-negative patients with diarrhea, and 2.5% of healthy controls. Shigella showed no association with disease or with diarrhea in HIV-1-positive patients [142]. Similar findings were made in Senegal and the Central African Republic [143,144].…”
Section: Enteroinvasive E Coli and Shigellasupporting
confidence: 77%
“…However, this finding is lower resistance when compared to a study reported in the University of Gondar Hospital [16] which shows high resistance to tetracycline (90%), cotrimoxazole (84.6%), ampicilin (78.9%) and chloramphenicol (67.8%) and lower resistance to gentamycin (12.2%) (19). As opposed to the 62% resistant to chloramphenicol that has been reported in a study in Gondar (25),the frequency of shigella strain resistant to against chloramphenicol was 0%. This is may be due to the former study is done in HIV /AIDS patients that were taking antibiotics frequently.…”
Section: Discussioncontrasting
confidence: 68%